Disseminated Mycobacterium avium infection in a young woman with sickle cell disease and iatrogenic iron overload

Abstract

A 29-year-old woman with known sickle cell disease (SCD) and iatrogenic iron overload presented to the emergency department with a recurrent pain crisis and fever. Blood cultures obtained at a recent prior admission for the same complaints grew M avium. Bone marrow biopsy revealed non-caseating granulomas, but stains for mycobacteria and fungi were negative. Disseminated non-tuberculous mycobacterial infections (NTMIs) occur almost exclusively in immunosuppressed patients. SCD is not considered a risk factor for the development of disseminated NTMIs, making diagnosis challenging in this population. However, a number of case reports describing disseminated NTMIs in patients with SCD have been published. This case adds to the current literature, suggesting SCD with iatrogenic iron overload is a possible risk factor for disseminated NTMIs. Potential mechanisms for this increased risk include 1) functional asplenia, 2) iatrogenic iron overload, 3) chronic indwelling central venous catheters, and 4) hydroxyurea use. Further investigation is required to describe the strength and mechanism of the relationship between SCD and disseminated NTMIs.

Keywords

Sickle cell disease / Iron overload / Disseminated mycobacterium avium / Immunocompromised state

References

[1] Piel FB, Steinberg MH, Rees DC. Sickle cell disease. New England Journal of Medicine. 2017; 376(16): 1561-73. PMid:28423290. https://doi.org/10.1056/NEJMra1510865

[2] Koch M, Rabinowitsch L. Die Tuberkulose der Vögel und ihre Beziehungen zur Säugetiertuberkulose. Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin. 1907; 190(1): 246-541. https://doi.org/10.1007/BF01948490

[3] Horsburgh Jr CR, Mason 3rd U, Farhi DC, et al. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine. 1985; 64(1):36-48. PMid:3880852. Available from: https://doi.org/10.1097/00005792-198501000-00003

[4] Strnad L, Winthrop K. Mycobacterium avium Complex. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed: Elsevier Health Sciences; 2020. p. 3035-46.

[5] Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. The Lancet Infectious Diseases. 2015; 15(8): 968-80. Available from: https://doi.org/10.1016/S1473-3099(15)00089-4

[6] Thorell EA, Sharma M, Jackson MA, et al. Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients. Journal of Pediatric Hematology/Oncology. 2006; 28(10): 678-81. PMid:17023829. Available from: https://journals.lww.com/jpho-online/Fulltext/2006/10000/Disseminated_Nontuberculous_Mycobacterial.8.aspx

[7] Chamsi-Pasha MA, Alraies MC, Alraiyes AH, et al. Mycobacterium avium complex-associated hemophagocytic lymphohistiocytosis in a sickle cell patient: an unusual fatal association. Case Reports in Hematology. 2013; 2013. PMid: 23762672. Available from: https://www.hindawi.com/journals/crihem/2013/291518/

[8] Esnakula AK, Mummidi SK, Oneal PA, et al. Sepsis caused by Mycobacterium terrae complex in a patient with sickle cell disease. Case Reports. 2013; 2013: bcr2013009159. PMid: 23645646. Available from: https://casereports.bmj.com/content/2013/bcr-2013-009159.short

[9] Shemisa K, Jafferjee N, Thomas D, et al. Mycobacterium avium complex infection in a patient with sickle cell disease and severe iron overload. Case Reports in Infectious Diseases. 2014; 2014. PMid: 25544913. Available from: https://www.hindawi.com/journals/criid/2014/405323/

[10] Edun B, Shah A, Durkin M, et al. Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters-the role of sickle cell anaemia. Infectious Diseases. 2017; 49(5): 341-6. PMid:27911152. Available from: https://www.tandfonline.com/doi/full/10.1080/23744235.2016.1262058

[11] Gilsdorf J, Suzanne D. Infections in asplenic patients. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases: Elsevier Health Sciences; 2020. p. 3713-21.

[12] Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sicklecell anemia. New England Journal of Medicine. 1969; 281(17): 923-6. PMid:5811425. Available from: https://www.nejm.org/doi/full/10.1056/NEJM196910232811703

[13] Piccin A, Smith OP, Murphy C, et al. Splenectomy in sickle cell anaemia: A cause of further crises? British Journal of Haematology. 2009; 145(1): 144-6. PMid:19183187. https://doi.org/10.1111/j.1365-2141.2008.07564.x

[14] Piccin A, Murphy C, Eakins E, et al. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment. European Journal of Haematology. 2019; 102(4): 319-30. PMid:30664257. https://doi.org/10.1111/ejh.13212

[15] Pearson HA, McIntosh S, Ritchey AK, et al. Developmental aspects of splenic function in sickle cell diseases. Blood. 1979; 53(3): 358-65. https://doi.org/10.1182/blood.V53.3.358.358

[16] Ganz T. Iron and infection. International Journal of Hematology. 2018; 107(1): 7-15. Available from: https://link.springer.com/article/10.1007%2Fs12185-017-2366-2

[17] Wright AC, Simpson LM, Oliver JD. Role of iron in the pathogenesis OF Vibrio VULNIFICUS infections. Infection and Immunity. 1981; 34(2): 503-7. PMid:7309236. https://doi.org/10.1128/iai.34.2.503-507.1981

[18] Piroth L, Meyer P, Bielefeld P, et al. Bactériémie à yersinia ET surcharge En fer. La Revue de Médecine Interne. 1997; 18(12): 932-8. https://doi.org/10.1016/S0248-8663(97)80112-9

[19] van Asbeck BS, Verbrugh HA, van Oost BA, et al. Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. BMJ. 1982; 284(6315): 542-4. PMid:6800535. https://doi.org/10.1136/bmj.284.6315.542

[20] Gordeuk VR, Delanghe JR, Langlois MR, et al. Iron status and the outcome of hiv infection: An overview. Journal of Clinical Virology. 2001; 20(3): 111-5. https://doi.org/10.1016/S1386-6532(00)00134-7

[21] Gordeuk V, McLaren C, MacPhail A, et al. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan’s 1929 thesis revisited. Blood. 1996; 87(8): 3470-6. PMid:8605366. Available from: https://ashpublications.org/blood/article/87/8/3470/124651/Associations-of-iron-overload-in-Africa-with

[22] Zarrouk V, Habibi A, Zahar JR, et al. Bloodstream infection in adults with sickle cell disease: association with venous catheters, Staphylococcus aureus, and bone-joint. Medicine. 2006; 85(1): 43-8. PMid:16523052. Available from: https://pubmed.ncbi.nlm.nih.gov/16523052/

[23] Platt OS. Hydroxyurea for the treatment of sickle cell anemia. New England Journal of Medicine. 2008; 358(13): 1362-9. PMid:18367739. Available from: https://pubmed.ncbi.nlm.nih.gov/18367739/

[24] Lova L, Groff A, Ravot E, et al. Hydroxyurea exerts a cytostatic but not immunosuppressive effect on T lymphocytes. AIDS. 2005; 19(2): 137-44. PMid:15668538. Available from: https://pubmed.ncbi.nlm.nih.gov/15668538/

[25] Steinberg MH, McCarthy WF, Castro O, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. American Journal of Hematology. 2010; 85(6): 403-8. PMid:20513116. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajh.21699

[26] Kuvibidila SR, Sandoval M, Lao J, et al. Plasma zinc levels inversely correlate with vascular cell adhesion molecule-1 concentration in children with sickle cell disease. Journal of the National Medical Association. 2006; 98(8): 1263. Available from: https://pubmed.ncbi.nlm.nih.gov/16916123/

[27] Larcher V, Wyke R, Davis L, et al.Defective yeast opsonisation and functional deficiency of complement in sickle cell disease. Archives of Disease in Childhood. 1982; 57(5): 343-6. PMid:7092289. Available from: https://adc.bmj.com/content/57/5/343.short

[28] Tamouza R, Neonato MG, Busson M, et al.Infectious complications in sickle cell disease are influenced by HLA class II alleles. Human Immunology. 2002; 63(3): 194-9. Available from: https://doi.org/10.1016/S0198-8859(01)00378-0

[29] Tapazoglou E, Prasad AS, Hill G, et al. Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease. The Journal of Laboratory and Clinical Medicine. 1985; 105(1): 19-22. Available from: https://www.translationalres.com/article/0022-2143(85)90083-6/fulltext